https://ntp.niehs.nih.gov/go/6148

TDMS Study 96007-05 Pathology Tables

NTP Experiment-Test: 96007-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                             TOXIC EQUIVALENCY FACTOR EVALUATION(PECDF)                        Date: 07/14/03
Route: GAVAGE                                                                                                     Time: 14:42:22
                                                       31 WEEK SSAC RATS
       Facility:  Battelle Columbus Laboratory
       Chemical CAS #:  57117-31-4
       Lock Date:  07/25/02
       Cage Range:  All
       Reasons For Removal:    25017 Scheduled Sacrifice
       Removal Date Range:     11/03/99 - 11/04/99
       Treatment Groups:       Include All
a  Number of animals examined microscopically at site and number of animals with lesion
                                                              Page   1
NTP Experiment-Test: 96007-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                             TOXIC EQUIVALENCY FACTOR EVALUATION(PECDF)                        Date: 07/14/03    
Route: GAVAGE                                                                                                     Time: 14:42:22    
____________________________________________________________________________________________________________________________________
         SPRAGUE-DAWLEY RATS FEMALE                0 NG/KG      6 NG/KG      20 NG/KG     44 NG/KG     92 NG/KG     200             
                                                                                                                    NG/KG           
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          98           98           98           98           98           98           
  Scheduled Sacrifice                                 16           16           16           16           16           16           
  Early Deaths                                                                                                                      
  Survivors                                                                                                                         
  Animals Examined Microscopically                    10           10           10           10           10           10           
____________________________________________________________________________________________________________________________________
 ALIMENTARY SYSTEM                                                                                                                  
   Liver                                              (10)         (10)         (10)         (10)         (10)         (10)         
      Basophilic Focus                                              2 (20%)                   1 (10%)                               
      Cholangiofibrosis                                                                                                 1 (10%)     
      Eosinophilic Focus                                                                                                1 (10%)     
      Fatty Change, Diffuse                                                                                1 (10%)                  
      Inflammation                                     9 (90%)     10 (100%)    10 (100%)    10 (100%)    10 (100%)    10 (100%)    
      Mixed Cell Focus                                 1 (10%)      3 (30%)      2 (20%)      1 (10%)      2 (20%)      1 (10%)     
      Mixed Cell Focus, Multiple                       4 (40%)      1 (10%)      3 (30%)      2 (20%)                   4 (40%)     
      Pigmentation                                                  1 (10%)      3 (30%)      4 (40%)      7 (70%)      8 (80%)     
      Bile Duct, Fibrosis                                                                                               1 (10%)     
      Bile Duct, Hyperplasia                                                                               1 (10%)                  
      Hepatocyte, Hypertrophy                                       1 (10%)      3 (30%)      6 (60%)      8 (80%)      8 (80%)     
____________________________________________________________________________________________________________________________________
 CARDIOVASCULAR SYSTEM                                                                                                              
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 ENDOCRINE SYSTEM                                                                                                                   
   Adrenal Cortex                                     (10)                                                             (10)         
      Hypertrophy                                      1 (10%)                                                          2 (20%)     
   Pituitary Gland                                    (10)                                                             (10)         
      Hyperplasia                                      1 (10%)                                                                      
   Thyroid Gland                                      (10)         (10)         (10)         (10)         (10)         (10)         
      Follicular Cell, Hypertrophy                     2 (20%)      1 (10%)      5 (50%)      3 (30%)      2 (20%)      3 (30%)     
____________________________________________________________________________________________________________________________________
 GENERAL BODY SYSTEM                                                                                                                
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    2                                                              
NTP Experiment-Test: 96007-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                             TOXIC EQUIVALENCY FACTOR EVALUATION(PECDF)                        Date: 07/14/03    
Route: GAVAGE                                                                                                     Time: 14:42:22    
____________________________________________________________________________________________________________________________________
         SPRAGUE-DAWLEY RATS FEMALE                0 NG/KG      6 NG/KG      20 NG/KG     44 NG/KG     92 NG/KG     200             
                                                                                                                    NG/KG           
____________________________________________________________________________________________________________________________________
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 GENITAL SYSTEM                                                                                                                     
   Ovary                                              (10)         (10)         (10)         (10)         (10)         (10)         
      Atrophy                                          5 (50%)      7 (70%)      7 (70%)      6 (60%)      8 (80%)      9 (90%)     
      Cyst                                             1 (10%)                                1 (10%)                   2 (20%)     
   Uterus                                             (10)         (10)         (10)         (10)         (10)         (10)         
      Inflammation, Suppurative                                                               1 (10%)      1 (10%)      1 (10%)     
      Metaplasia, Squamous                             5 (50%)      6 (60%)      3 (30%)      5 (50%)      6 (60%)      3 (30%)     
      Endometrium, Hyperplasia, Cystic                 4 (40%)      2 (20%)      4 (40%)      6 (60%)      7 (70%)      8 (80%)     
____________________________________________________________________________________________________________________________________
 HEMATOPOIETIC SYSTEM                                                                                                               
   Spleen                                             (10)                                                             (10)         
      Pigmentation                                    10 (100%)                                                        10 (100%)    
   Thymus                                             (10)         (10)         (10)         (10)         (10)         (10)         
      Atrophy                                          1 (10%)                                2 (20%)                   5 (50%)     
____________________________________________________________________________________________________________________________________
 INTEGUMENTARY SYSTEM                                                                                                               
   Mammary Gland                                      (10)                      (2)          (1)          (1)          (10)         
      Cyst                                             1 (10%)                                             1 (100%)                 
      Hyperplasia                                      1 (10%)                                                                      
____________________________________________________________________________________________________________________________________
 MUSCULOSKELETAL SYSTEM                                                                                                             
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 NERVOUS SYSTEM                                                                                                                     
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 RESPIRATORY SYSTEM                                                                                                                 
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    3                                                              
NTP Experiment-Test: 96007-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                             TOXIC EQUIVALENCY FACTOR EVALUATION(PECDF)                        Date: 07/14/03    
Route: GAVAGE                                                                                                     Time: 14:42:22    
____________________________________________________________________________________________________________________________________
         SPRAGUE-DAWLEY RATS FEMALE                0 NG/KG      6 NG/KG      20 NG/KG     44 NG/KG     92 NG/KG     200             
                                                                                                                    NG/KG           
____________________________________________________________________________________________________________________________________
 SPECIAL SENSES SYSTEM                                                                                                              
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 URINARY SYSTEM                                                                                                                     
   None                                                                                                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    4                                                              
NTP Experiment-Test: 96007-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                             TOXIC EQUIVALENCY FACTOR EVALUATION(PECDF)                        Date: 07/14/03    
Route: GAVAGE                                                                                                     Time: 14:42:22    
____________________________________________________________________________________________________________________________________
         SPRAGUE-DAWLEY RATS FEMALE                200 NG/                                                                          
                                                   KG STOP                                                                          
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          50                                                                            
  Early Deaths                                                                                                                      
  Survivors                                                                                                                         
  Animals Examined Microscopically                                                                                                  
____________________________________________________________________________________________________________________________________
 ALIMENTARY SYSTEM                                                                                                                  
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 CARDIOVASCULAR SYSTEM                                                                                                              
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 ENDOCRINE SYSTEM                                                                                                                   
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 GENERAL BODY SYSTEM                                                                                                                
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 GENITAL SYSTEM                                                                                                                     
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 HEMATOPOIETIC SYSTEM                                                                                                               
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 INTEGUMENTARY SYSTEM                                                                                                               
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    5                                                              
NTP Experiment-Test: 96007-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                             TOXIC EQUIVALENCY FACTOR EVALUATION(PECDF)                        Date: 07/14/03    
Route: GAVAGE                                                                                                     Time: 14:42:22    
____________________________________________________________________________________________________________________________________
         SPRAGUE-DAWLEY RATS FEMALE                200 NG/                                                                          
                                                   KG STOP                                                                          
____________________________________________________________________________________________________________________________________
 MUSCULOSKELETAL SYSTEM                                                                                                             
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 NERVOUS SYSTEM                                                                                                                     
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 RESPIRATORY SYSTEM                                                                                                                 
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 SPECIAL SENSES SYSTEM                                                                                                              
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 URINARY SYSTEM                                                                                                                     
   None                                                                                                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    6                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------